Page 103 | Certara

Blog

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…

CertaraApril 21, 2023

Conference

AMWA 2025 Medical Writing and Communications Conference

–

CertaraApril 20, 2023

On-Demand Webinar

Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis

Published research and literature-based content holds valuable insight that can inform clinical trial execution and…

CertaraApril 19, 2023

On-Demand Webinar

Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development

Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…

CertaraApril 17, 2023

Case Study

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…

CertaraApril 17, 2023

White Paper

Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program

This white paper focuses on best practices for developing a CMC strategy for orally administered…

CertaraApril 13, 2023

Case Study

Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints

Repurposed data and advanced analytics can be used to validate a surrogate endpoint. A surrogate…

CertaraApril 13, 2023

Press Coverage

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Published: April 12, 2023 This is the German article written by Dr. Fabian Rauscher, Scientific…

CertaraApril 12, 2023

Video

Milestone Achieved: Simcyp 100

CertaraApril 11, 2023

Brochure

Drug Discovery & Development with Deep Learning Advanced Analytics

Solutions to Meet All Needs: From Small Biotech to Large Global Pharma

CertaraApril 6, 2023